quiescenc
hallmark
cell
latent
infect
revers
quiescenc
effect
approach
reactiv
latent
hiv
cell
cultur
caus
deleteri
cytokin
dysregul
patient
report
key
regul
tcell
quiescenc
promot
latenc
suppress
product
hiv
infect
rest
cell
inhibit
induc
er
stress
activ
two
associ
transcript
factor
activ
transcript
factor
nuclear
factor
activ
cell
nfat
factor
associ
hiv
chromatin
necessari
hiv
reactiv
inde
inhibit
pkrlike
endoplasm
reticulum
kinas
perk
known
link
er
stress
calcineurin
calciumdepend
regul
nfat
synergist
suppress
hiv
reactiv
induc
inhibit
thu
studi
uncov
novel
link
er
stress
hiv
infect
could
therapeut
exploit
select
revers
tcell
quiescenc
reduc
size
latent
viral
reservoir
major
barrier
erad
human
immunodefici
viru
infect
patient
persist
latent
infect
cell
primarili
memori
cell
cell
rare
longliv
gener
quiescent
although
antiretrovir
therapi
art
effect
suppress
hiv
replic
therapi
interrupt
result
reactiv
latent
reservoir
necessit
lifelong
treatment
cure
one
strategi
elimin
latent
infect
cell
activ
viru
product
use
latenc
revers
agent
lra
object
trigger
cell
death
virusinduc
cytolysi
immun
clearanc
effici
viral
reactiv
requir
calibr
degre
activ
avoid
induc
polyclon
cell
activ
cytokin
storm
would
negat
potenti
benefit
known
lra
target
variou
pathway
induc
viral
reactiv
includ
pkc
agonist
eg
prostratin
epigenet
modul
eg
hdac
bromodomain
inhibitor
modul
mtor
signal
pathway
howev
date
clinic
trial
exist
lra
demonstr
success
reduct
latent
reservoir
thu
better
understand
hiv
latenc
establish
maintain
need
improv
design
intervent
forkhead
box
foxo
protein
famili
compris
evolutionarili
conserv
transcript
factor
foxomedi
gene
regul
determin
part
local
upon
phosphoryl
upstream
kinas
exit
nucleu
remain
inact
differ
human
foxo
isoform
influenc
multipl
pathway
includ
cell
cycl
arrest
glucos
metabol
oxid
stress
regul
apoptosi
dna
damag
respons
immun
system
foxo
protein
regul
set
gene
involv
maintain
quiescenc
cellfat
differenti
cell
valu
repres
two
independ
experi
e
ratio
product
versu
latent
popul
upon
increas
concentr
wt
cell
line
data
repres
mean
sd
triplic
valu
repres
two
independ
experi
fit
model
biorxiv
preprint
sd
least
three
independ
experi
e
jlat
cell
line
treat
h
increas
concentr
fenretinid
yaxi
ionomycin
xaxi
alon
combin
analyz
fac
hivgfp
reactiv
report
percentag
gfpexpress
cell
gfp
cell
upper
panel
viabil
measur
fac
bottom
panel
data
repres
averag
three
independ
experi
memori
cell
promot
effectorlik
cytotox
phenotyp
context
immun
age
chronic
infect
downregul
memori
cell
elit
control
hiv
patient
promot
persist
cell
furthermor
foxo
protein
neg
regul
hiv
transcript
tatmedi
repress
inhibit
acceler
product
infect
foxo
activ
especi
promot
maintain
quiescent
state
memori
cell
hiv
establish
latenc
hypothes
directli
indirectli
induc
hiv
latenc
identifi
pathway
link
hiv
latenc
activ
via
er
stress
signal
without
gener
cell
activ
shown
inhibit
prevent
latenc
establish
also
success
purg
viru
latent
reservoir
propos
combin
earli
art
inhibitor
may
downsiz
latent
reservoir
test
potenti
inhibit
affect
latenc
use
secondgener
dualcolor
report
viru
hivgko
inhibitor
figur
system
latent
infect
cell
express
fluoresc
protein
control
promot
cell
contain
product
activ
viru
express
gfp
fluorophor
latter
control
ltr
upon
treatment
increas
concentr
proport
latent
infect
cell
decreas
despit
signific
chang
total
infect
rate
viabil
figur
concomitantli
proport
activ
infect
cell
increas
expect
inhibitor
observ
cell
cultur
system
nm
near
vitro
nm
thu
inhibit
prevent
latenc
establish
increas
ratio
activ
latent
infect
cell
next
sought
confirm
specif
end
perform
cellular
thermal
shift
assay
cetsa
foxo
isoform
express
cell
cetsa
uniqu
capabl
evalu
biophys
bind
physiolog
condit
live
cell
bind
consid
posit
signific
chang
thermal
denatur
profil
protein
upon
addit
versu
without
drug
assess
western
blot
extend
data
figur
observ
shift
melt
curv
upon
treatment
wherea
chang
found
either
figur
confirm
specif
inhibitor
similar
result
observ
nm
extend
data
figur
c
interrog
role
foxo
famili
member
latenc
establish
gener
singl
knockdown
crispr
interfer
crispri
cell
figur
foxo
protein
control
cell
cycl
promot
quiescent
state
knockdown
led
increas
prolifer
rate
extend
data
figur
agreement
previou
find
human
bladder
cancer
cell
breast
adenocarcinoma
cell
howev
downregul
increas
product
infect
decreas
latent
infect
figur
furthermor
knockdown
render
infect
cell
sensit
treatment
shift
figur
extend
data
figur
f
taken
togeth
data
indic
pharmacolog
genet
inhibit
decreas
establish
latenc
jlat
clonal
cell
line
jurkat
cell
contain
stabli
integr
latent
hxb
env
proviru
gfp
report
gene
place
nef
gene
system
reactiv
establish
latenc
monitor
gfp
express
hour
treatment
stimul
gfp
mrna
express
jlat
cell
similar
degre
known
lra
jlat
cell
indic
inhibit
also
revers
establish
latenc
figur
major
effect
cell
viabil
observ
figur
maxim
activ
seen
hour
activ
progress
increas
time
point
treatment
also
increas
hivdriven
gfp
protein
express
dosedepend
manner
determin
flow
cytometri
figur
antagon
tatmedi
transactiv
promot
repress
viral
transactiv
tat
test
abil
revers
hiv
latenc
jlat
cell
without
tat
increas
gfp
express
jlat
cell
contain
tat
cell
indic
effect
inhibit
hiv
reactiv
tatindepend
figur
extend
data
figur
effect
cell
viabil
observ
figur
rule
effect
base
clonal
variat
provir
integr
site
compar
hiv
reactiv
four
jlat
clonal
cell
line
latent
insert
distinct
genom
site
hour
treatment
reactiv
hiv
cell
line
determin
percentag
gfp
cell
figur
median
fluoresc
intens
extend
data
figur
cell
line
viabil
unaffect
treatment
induc
gfp
express
earli
hour
treatment
expect
figur
thu
effect
independ
provir
integr
site
given
differ
time
cours
hiv
reactiv
specul
lra
target
differ
mechan
reactiv
might
synerg
test
hypothesi
cotreat
multipl
jlat
line
increas
concentr
extend
data
figur
use
bliss
independ
model
assess
dose
combin
result
greater
addit
effect
observ
synergist
effect
across
differ
dose
clone
figur
upper
panel
found
major
chang
viabil
cotreat
cell
line
figur
bottom
panel
collect
data
show
revers
establish
latenc
inhibit
indic
molecular
mechan
activ
distinct
order
verifi
result
primari
tcell
model
hiv
latenc
measur
capac
inhibit
impair
hiv
latenc
establish
infect
rest
cell
anonym
blood
donor
hivgko
treat
cell
increas
dose
hour
observ
previous
cell
inhibit
promot
product
infect
decreas
latenc
figur
also
test
abil
revers
establish
hiv
latenc
primari
cell
spininfect
rest
cell
pseudotyp
hiv
report
viru
contain
firefli
luciferas
gene
day
cultur
cell
reactiv
luciferas
express
respons
increas
concentr
inhibitor
figur
well
respons
gener
cell
activ
induc
either
combin
phytohemagglutinin
antibodi
direct
receptor
extend
data
figur
notabl
inhibit
induc
gener
cell
activ
measur
express
activ
marker
cell
surfac
extend
data
figur
combin
nm
low
dose
prostratin
nm
natur
protein
kinas
c
activ
induc
partial
tcell
activ
significantli
increas
effect
primari
cell
mirror
synergist
effect
tnfa
jlat
cell
chang
primari
tcell
viabil
observ
respons
inhibit
figur
replic
observ
cell
isol
five
hivinfect
patient
antiretrovir
therapi
least
month
undetect
viral
load
copiesml
cell
treat
ex
vivo
two
concentr
nm
prostratin
nm
combin
thereof
day
hiv
rna
induct
measur
digit
droplet
pcr
ddpcr
twofold
induct
observ
treatment
alon
significantli
enhanc
prostratin
cotreat
similar
level
achiev
pmai
treatment
figur
result
confirm
role
establish
mainten
hiv
latenc
primari
rest
cell
determin
inhibit
chang
transcript
rest
cell
use
rna
sequenc
rnaseq
primari
cell
treat
dmso
hour
first
time
point
reactiv
observ
identifi
gene
significantli
upregul
gene
significantli
downregul
q
figur
use
gene
ontolog
enrich
analysi
integr
differenti
express
transcript
biolog
pathway
observ
signific
enrich
gene
involv
biosynthesi
lserin
eg
phgdh
trna
charg
eg
mar
var
gar
biosynthesi
purin
eg
pfa
paic
coenzym
folat
metabol
eg
among
gene
upregul
inhibit
downregul
gene
includ
involv
product
eg
endosom
tolllik
receptor
figur
rnaseq
result
valid
measur
read
count
select
gene
repres
differ
pathway
extend
data
figur
well
realtim
quantit
pcr
figur
although
connect
prevent
glycolysi
treatment
affect
express
glycolyt
enzym
upstream
regul
analysi
identifi
top
regul
gene
chang
figur
specif
algorithm
predict
highli
inhibit
activ
figur
known
inhibit
transcript
factor
specif
upregul
protein
level
part
integr
stress
respons
involv
phosphoryl
translat
initi
factor
variou
stressspecif
kinas
rnaseq
analysi
cell
hour
treatment
show
upregul
pathway
includ
ribosom
larg
subunit
assembl
rrna
process
unfold
protein
respons
upr
support
role
integr
stress
respons
gene
chang
inhibit
extend
data
figur
c
line
hypothesi
inhibit
increas
express
protein
level
cell
across
multipl
donor
figur
bind
siv
hiv
ltr
activ
relat
human
tcell
leukemia
viru
type
perform
chromatin
immunoprecipit
chip
experi
test
whether
bind
hiv
ltr
respons
inhibit
low
level
bound
hiv
ltr
chromatin
untreat
jlat
cell
recruit
enrich
treatment
figur
also
observ
mark
increas
rna
polymeras
ii
recruit
hiv
promot
inhibit
consist
hiv
transcript
reactiv
rela
subunit
nfkb
transcript
factor
key
regul
hiv
transcript
respons
cell
activ
tnfa
exposur
recruit
hiv
ltr
treatment
significantli
enrich
tnfa
treatment
expect
figur
nuclear
factor
activ
cell
nfat
occupi
nfkb
bind
site
hiv
ltr
activ
calcium
mobil
tcell
activ
rather
protein
kinas
c
activ
case
nfkb
nfat
markedli
enrich
hiv
ltr
inhibit
figur
indic
rest
cell
suppress
noncanon
transcript
program
control
hiv
transcript
without
nfkb
nfat
result
explain
synergi
observ
tnfa
prostratin
compound
activ
hiv
nfkb
investig
integr
stress
respons
potenti
role
hiv
reactiv
evalu
effect
combin
inhibitor
differ
upstream
kinas
doublestrand
rnadepend
protein
kinas
r
pkr
activ
viral
infect
pkrlike
endoplasm
reticulum
kinas
perk
activ
respons
er
stress
gener
control
nonderepress
kinas
activ
amino
acid
defici
treatment
pharmacolog
inhibitor
perk
pkr
reduc
hiv
reactiv
consist
model
inhibit
activ
er
stress
integr
stress
respons
figur
extend
data
figur
b
contrast
hiv
reactiv
affect
perk
inhibit
figur
diminish
upon
pkr
inhibitor
treatment
extend
data
figur
b
find
underscor
differ
molecular
mechan
underli
latenc
revers
two
activ
nfat
also
recruit
hiv
ltr
inhibit
regul
perk
activ
test
effect
cyclosporin
csa
potent
inhibitor
calcium
releas
nfat
mobil
known
reduc
hiv
transcript
activ
increas
concentr
csa
suppress
hiv
reactiv
induc
support
specif
role
nfat
inhibitormedi
latenc
revers
figur
treatment
perk
inhibitor
csa
alon
suppress
hiv
reactiv
perki
csa
wherea
combin
almost
complet
block
viral
reactiv
figur
result
suggest
nfat
import
hiv
reactiv
respons
inhibit
transcript
factor
link
er
stress
either
activ
perk
mobil
erresid
calcium
store
test
concept
er
stress
reactiv
hiv
latenc
treat
jlat
cell
known
induc
er
stress
includ
thapsigargin
sarcoer
ca
atpas
serca
inhibitor
brefeldin
retrograd
vesicular
transport
inhibitor
fenretinid
clinic
test
synthet
retinoid
deriv
result
reactiv
fenretinid
treatment
act
strongli
figur
activ
agent
associ
dosedepend
cellular
toxic
explain
known
function
potent
apoptosi
induc
extend
data
figur
minim
toxic
caus
high
concentr
fenretinid
combin
nontox
dose
fenretinid
increas
amount
ionomycin
mobil
addit
ca
ion
although
ionomycin
alon
suffici
induc
hiv
reactiv
extend
data
figur
combin
significantli
increas
effect
fenretinid
alon
minim
cellular
toxic
figur
extend
data
figur
data
support
model
interfer
potenti
lowlevel
continu
er
stress
rest
cell
suppress
activ
nfat
therebi
promot
hiv
latenc
inhibit
activ
unleash
er
stress
signal
calcium
releas
mobil
two
transcript
factor
activ
ltr
revers
viral
latenc
figur
uncov
link
er
stress
work
describ
new
mechan
hiv
latenc
establish
maintain
quiescent
cell
result
agreement
work
link
er
stress
cell
activ
show
foxo
activ
protect
quiescent
cell
oxid
stress
extend
studi
show
effect
involv
nfkb
activ
activ
control
nfat
mobil
system
interact
regul
glucos
metabol
osteoblast
foxo
activ
suppress
calcineurinnfat
activ
reduc
oxid
stress
cardiac
physiolog
malfunct
er
like
excess
secretori
activ
ca
deplet
presenc
misfold
protein
pivot
role
life
cycl
virus
establish
latent
infect
er
stress
activ
unfold
protein
respons
necessari
replic
mani
virus
herp
virus
virus
known
hijack
unfold
protein
respons
promot
express
like
hepat
c
viru
west
nile
viru
respiratori
syncyti
viru
japanes
enceph
viru
human
cytomegaloviru
dengu
viru
denv
infecti
bronchiti
viru
ibv
context
hiv
work
show
er
stress
promot
activ
hiv
infect
act
critic
regul
process
rest
cell
result
agre
previou
find
infect
associ
enhanc
express
er
stress
sensor
perk
pbmc
viral
protein
transactiv
tat
induc
er
stress
astrocyt
nfat
classic
er
stressinduc
factor
one
four
new
transcript
factor
found
activ
er
stress
addit
close
connect
intracellular
calcium
level
link
er
major
intracellular
calcium
store
prolong
er
stress
associ
calcium
releas
erresid
chaperon
bind
immunoglobulin
protein
bip
import
sensor
unfold
protein
calciumregul
remain
unknown
caus
er
stress
unleash
inhibit
quiescent
cell
everi
protein
enter
er
potenti
trigger
respons
perk
one
three
sensor
er
nonactiv
maintain
monomer
state
bound
bip
bip
sens
accumul
misfold
protein
dissoci
perk
allow
kinas
dimer
transautophosphoryl
phosphoryl
perk
promot
phosphoryl
impair
translat
mrna
except
transcript
like
specif
express
presenc
multipl
open
read
frame
untransl
region
experi
requir
clarifi
potenti
involv
downstream
pathway
hiv
reactiv
better
understand
molecular
link
er
stress
proteostasi
perk
phosphoryl
enhanc
insulin
respons
effect
perk
activ
yet
report
nevertheless
discoveri
new
mechan
open
door
promis
therapeut
option
especi
consid
synergist
effect
inhibit
combin
lra
latenc
revers
effect
er
stressinduc
agent
fenretinid
current
earli
clinic
trial
cancer
import
aspect
cytolyt
activ
cell
key
contributor
success
shock
kill
strategi
strengthen
treatment
inhibitor
contrast
hdac
inhibitor
suppress
cell
activ
combin
inhibitor
earli
art
seem
especi
promis
given
neg
effect
latenc
establish
potenti
prolong
time
window
intervent
prevent
maxim
reservoir
establish
cell
line
primari
cultur
jlat
cell
line
clone
obtain
verdin
green
laboratori
gladston
institut
gener
line
jurkat
cell
jlat
cell
cultur
rpmi
corn
va
usa
supplement
fb
corn
va
usa
lglutamin
corn
va
usa
penicillinstreptomycin
corn
va
usa
cell
line
express
gift
lab
johnathan
weissman
ucsf
maintain
appropri
volum
rpmi
medium
supplement
fetal
bovin
serum
serum
plu
ii
sigma
mo
usa
penicillinstreptomycin
cell
atcc
cultur
dmem
corn
va
usa
supplement
fb
glutamin
uml
penicillinstreptomycin
shortterm
passag
use
experi
primari
cell
isol
peripher
blood
mononuclear
cell
pbmc
enrich
via
neg
select
easysep
human
cell
isol
kit
stemcel
technolog
canada
primari
cell
cultur
rpmi
supplement
fb
lglutamin
penicillinstreptomycin
viru
product
pseuodtyp
hivgko
viral
stock
gener
cotransfect
standard
calcium
phosphat
method
cell
plasmid
encod
hivgko
plasmid
encod
dualtrop
envelop
vesicular
stomat
viru
g
protein
vsvg
respect
medium
chang
h
transfect
supernat
collect
hour
centrifug
min
rpm
rt
filter
membran
clear
cell
debri
concentr
ultracentrifug
g
h
viruslik
particl
vlp
similarli
gener
describ
previous
cell
cotransfect
plasmid
encod
vprvpx
plasmid
encod
packag
vector
plasmid
padvantag
dna
flask
concentr
virion
resuspend
complet
media
store
viru
concentr
estim
titrat
use
flaq
assay
hivgko
vlp
rapid
titer
kit
clontech
cell
infect
cell
line
express
spinocul
h
rpm
hivgko
vsvg
pseudotyp
dualreport
viru
encod
gfp
moi
follow
vivo
cultur
complet
rpmi
medium
purifi
cell
isol
healthi
peripher
blood
cell
also
spinocul
vsvg
pseudotyp
viru
encod
luciferas
report
concentr
per
cell
figur
purifi
rest
cell
infect
vlp
day
cell
spininfect
well
vbottom
plate
cellswel
ng
vlp
per
cell
final
volum
h
rpm
incub
follow
day
fresh
complet
rpmi
without
differ
drug
ad
well
final
later
treat
untreat
cell
spininfect
hivgko
describ
previous
briefli
cell
spininfect
serial
dilut
hivgko
dilut
start
ng
h
rpm
spininfect
fresh
drug
ad
media
cell
cultur
addit
day
infect
cell
analyz
flow
cytometri
day
postinfect
rest
cell
treat
prehivgko
infect
nm
drug
concentr
ad
onto
cell
right
hivgko
spininfect
wash
away
data
analysi
cell
seed
drugsuppl
media
triplic
onto
plate
target
cell
densiti
x
cellsml
incub
h
respect
prepar
flow
cytometri
cell
wash
vshape
plate
x
g
min
stain
fixabl
viabil
dye
efluor
thermofish
scientif
cell
activ
analysi
express
measur
flow
cytometri
gate
cell
use
fitclabel
antibodi
ebiosci
apcconjug
antibodi
ebiosci
percplabel
antibodi
biolegend
bd
horizon
stain
perform
min
ice
fac
buffer
pb
fb
analysi
jlat
cell
measur
bd
facscalibur
system
bd
bioscienc
uncompens
set
infect
uninfect
cell
data
collect
use
bd
lsrii
flow
cytomet
bd
bioscienc
data
analyz
use
flowjo
softwar
tree
star
viabil
cell
viabil
surviv
measur
flow
cytometri
gate
forward
side
scatter
analysi
use
fixabl
viabil
dye
efluor
thermofish
scientif
trypan
blue
dye
exclus
use
evalu
cell
viabil
cetsa
assay
cell
reactiv
studi
hiv
donor
cell
aliquot
sampl
briefli
mix
equal
volum
wv
trypan
blue
dye
solut
gibco
ny
usa
count
cell
abil
exclud
trypan
blue
consid
viabl
cetsa
cell
freshli
seed
one
day
experi
day
experi
equal
number
cell
count
moxi
mini
autom
cell
counter
orflo
cell
per
data
point
seed
cell
cultur
flask
vwr
pa
usa
appropri
volum
cultur
medium
cell
expos
nm
equal
dmso
volum
hour
incub
follow
incub
cell
harvest
wash
pb
dilut
pb
supplement
edtafre
complet
proteas
inhibitor
cocktail
roch
cell
divid
aliquot
heat
individu
differ
temperatur
minut
thermal
cycler
biorad
follow
cool
minut
room
temperatur
cell
suspens
freezethaw
three
time
liquid
nitrogen
solubl
fraction
separ
cell
debri
centrifug
g
minut
supernat
transfer
new
microcentrifug
tube
analyz
sdspage
follow
immunoblot
analysi
cetsa
experi
perform
triplic
differ
day
immunoblot
result
subject
densitometr
analysi
imag
j
melt
temperatur
determin
prism
graphpad
use
nonlinear
leastsquar
regress
fit
log
x
h
h
hill
slope
variabl
viabil
cell
assess
triplic
trypan
blue
exclus
individu
sgrna
human
librari
clone
lentivir
vector
express
either
puromycin
resist
cassett
addgen
modifi
vector
express
blasticidin
resist
cassett
gift
nevan
krogan
ucsf
lentivirus
prepar
singl
knockdown
cell
line
express
transduc
singl
construct
select
either
puromycin
sigmaaldrich
blasticidin
sigmaaldrich
see
tabl
ggagcaggaagctgagtgag
blasticidin
total
rna
sampl
extract
use
directzol
rna
kit
zymogen
cdna
gener
use
ng
cell
ng
total
rna
jlat
superscript
iii
revers
transcript
thermofish
oligo
dt
thermofish
quantit
rtpcr
done
use
maxima
sybr
green
qpcr
master
mix
thermo
scientif
sd
softwar
appli
biosystem
total
volum
sybr
green
qpcr
reaction
contain
maxima
sybr
greenrox
qpcr
master
mix
thermofish
dilut
cdna
nmol
forward
revers
primer
reaction
run
follow
min
min
follow
cycl
see
tabl
qrtpcr
primer
list
primer
effici
around
dissoci
curv
analysi
end
pcr
confirm
presenc
singl
specif
product
qpcr
independ
repeat
least
three
time
averag
compar
use
standard
deviat
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
tabl
qrtpcr
primer
list
studi
sampl
hivinfect
particip
zuckerberg
san
francisco
gener
hospit
clinic
scope
cohort
individu
met
criteria
start
art
chronic
infect
suppress
art
undetect
plasma
rna
level
copiesml
minimum
one
year
ucsf
committe
human
research
approv
studi
particip
gave
inform
written
consent
enrol
peripher
blood
mononuclear
cell
pbmc
isol
fresh
blood
ml
use
lymphocyt
separ
medium
corn
cell
isol
use
neg
select
easysep
kit
stemcel
accord
manufactur
instruct
isol
cell
aliquot
densiti
cell
per
well
ml
rpmi
medium
supplement
fb
correspond
drug
drug
prepar
cultur
medium
stock
solut
dissolv
dmso
h
treatment
total
rna
cell
extract
mirneasi
kit
qiagen
option
oncolumn
dnase
treatment
step
follow
turbo
tm
dnase
invitrogen
treatment
post
isol
rna
quantifi
use
nanodrop
spectrophotomet
nanodrop
technolog
superscript
iii
rt
firststrand
synthesi
system
invitrogen
use
reversetranscrib
ng
rna
random
hexam
invitrogen
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
cycl
second
minut
follow
minut
thermalcycl
strip
place
deck
raindrop
sens
instrument
second
microfluid
chip
raindrop
sens
chip
use
singl
droplet
fluoresc
measur
data
analyz
use
raindrop
analyst
softwar
two
dimension
histogram
fam
intens
xaxi
vic
intens
yaxi
normal
rna
input
drug
combin
normal
dmso
control
calcul
fold
induct
rnaseq
ingenu
pathway
analysi
rna
prepar
cell
use
qiagen
rneasi
plu
kit
gladston
institut
genom
core
carri
downstream
process
rna
sampl
strandspecif
cdna
librari
prepar
use
nugen
ovat
kit
nugen
librari
deep
sequenc
nextseq
use
singleend
bp
sequenc
rnaseq
analysi
done
use
illumina
rnaexpress
applic
v
briefli
align
rnaseq
read
perform
star
align
align
align
read
gene
differenti
gene
express
analyz
pathway
analysi
carri
use
ingenu
pathway
analysi
gene
ontolog
amigo
term
enrich
tool
ingenu
analysi
entir
dataset
upload
twodirect
analysi
carri
use
filter
restrict
analysi
differenti
express
gene
refer
manufactur
websit
http
wwwingenuitycom
detail
gene
ontolog
individu
list
gene
upload
analyz
separ
copyright
holder
preprint
version
post
april
input
dna
treat
rnase
h
new
england
biolab
proteinas
k
sigmaaldrich
min
immunoprecipit
chromatin
quantifi
realtim
pcr
use
maxima
sybr
green
qpcr
master
mix
thermo
scientif
abi
sequenc
detect
system
appli
biosystem
sd
softwar
appli
biosystem
use
analysi
specif
pcr
reaction
confirm
melt
curv
analysi
use
dissoci
curv
softwar
appli
biosystem
chromatin
immunoprecipit
qpcr
repeat
least
three
time
repres
result
shown
primer
sequenc
hiv
ltr
forward
atctaccacacacaaggctac
hiv
ltr
revers
gtactaacttgaagcaccatcc
hiv
ltr
forward
agtgtgtgcccgtctgttgt
hiv
ltr
revers
ttcgctttcaggtccctgtt
statist
analysi
two
group
compar
use
twotail
student
ttest
multipl
comparison
control
calcul
use
twoway
anova
follow
dunnett
test
data
present
mean
sd
biolog
replic
statist
signific
indic
figur
follow
pvalu
p
p
p
p
complet
array
dataset
rna
sequenc
data
associ
figur
b
extend
data
figur
avail
gene
express
omnibu
access
number
figur
specif
regul
hiv
latenc
establish
schemat
represent
hivgko
duallabel
report
cell
treat
increas
concentr
inhibitor
hivgko
infect
day
percentag
latent
product
infect
cell
quantifi
fac
upper
panel
amount
product
latent
infect
cell
bar
total
cell
viabil
dot
repres
experi
lower
panel
ratio
product
versu
latent
popul
rel
total
infect
rate
upon
increas
concentr
treatment
data
repres
mean
sd
triplic
valu
repres
three
independ
experi
b
cetsamelt
curv
shift
upon
presenc
absenc
nm
cell
band
intens
obtain
western
blot
analysi
normal
highest
western
blot
signal
rel
foxoband
intens
plot
correspond
incub
temperatur
nonlinear
leastsquar
regress
fit
appli
data
repres
mean
sd
three
independ
experi
except
c
effici
knockdown
two
differ
sgrna
determin
western
blot
cell
transduc
nc
neg
control
sgrna
lentivirus
use
control
left
graph
percentag
product
latent
cell
rel
total
infect
rate
cell
viabil
differ
singl
knockdown
cell
line
right
graph
ratio
product
versu
latent
popul
cell
line
knockdown
data
repres
mean
sd
triplic
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
treat
increas
concentr
h
hivgfp
reactiv
bar
cell
viabil
dot
analyz
fac
hivgfp
reactiv
report
percentag
gfpexpress
cell
gfp
cell
data
repres
averag
sd
least
three
independ
experi
experi
fig
perform
jlat
cell
line
data
repres
averag
sd
least
three
independ
experi
ngml
use
control
e
jlat
cell
line
treat
h
increas
concentr
yaxi
xaxi
alon
combin
analyz
fac
calcul
synergi
drug
combin
use
bliss
independ
model
appli
hivgfp
reactiv
measur
percentag
gfpexpress
cell
gfp
cell
synergi
purpl
cell
viabil
grey
data
point
repres
mean
effect
three
independ
experi
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
schemat
represent
hivgko
duallabel
report
strategi
use
treat
cell
purifi
blood
healthi
donor
pretreat
h
increas
concentr
infect
hivgko
rest
cell
treat
day
amount
pretreat
top
panel
show
ratio
product
versu
latent
popul
infect
cell
four
differ
healthi
donor
treatment
lower
panel
show
histogram
plot
percent
live
cell
drug
treatment
rel
control
data
repres
mean
sd
four
differ
donor
b
schemat
represent
luciferas
report
viru
experiment
procedur
primari
cell
briefli
cell
purifi
blood
healthi
donor
infect
luciferas
day
viru
reactiv
day
increas
concentr
prostratin
alon
combin
presenc
raltegravir
hiv
reactiv
measur
luciferas
activ
cell
viabil
flow
cytometri
data
mean
sem
least
individu
donor
c
fold
chang
cellassoci
mrna
express
measur
ddpcr
cell
hivinfect
patient
antiretroviraltherapi
undetect
viral
load
treat
ngml
nm
pma
ionomycin
pmai
dmso
ctl
prostratintr
cell
led
increas
fold
chang
cellassoci
hiv
mrna
express
cell
viabil
assess
trypan
blue
exclus
data
repres
mean
sd
nine
independ
experi
pvalu
p
p
p
p
rel
ctl
dmso
p
rel
nm
nm
versu
dmso
control
h
upregul
blue
downregul
red
gene
qvalu
fold
chang
respect
b
go
pathway
analysi
dysregul
canon
pathway
upand
downregul
gene
c
confirm
upor
downregul
express
h
treatment
specif
gene
alter
pathway
rtqpcr
normal
